ASML Research Update — September 19, 2026 (Updated)
Updated Thesis
ASML Holding N.V. is the Dutch semiconductor equipment maker that supplies lithography, metrology, and inspection systems, including the extreme ultraviolet (EUV) machines required to pattern the most advanced logic and memory chips, and it holds what current coverage describes as a near-monopoly on those EUV tools. The business quality is genuinely high: TTM gross margin of 52.7%, TTM operating margin of 35.4%, TTM net margin of 30.1%, and ROE of 52.4% show exceptional pricing power and capital efficiency, while revenue grew 21.3% and earnings grew 27.4% in the most recent quarter, placing the company in an investing phase.
The investment grade as of this refresh is C — average business quality. A-tier business, D-tier valuation: 0.7% downside to $1732.49 fair value, with the shares expensive versus historical multiples despite a 32.2% consensus target upside.
Key Metrics at a Glance
- Revenue growth: +21.3% year over year
- Net margin: 30.1%
- Fair value upside: -0.7% to our estimate of $1732
Current price: $1744.61
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. ASML Holding N.V. remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full ASML research →](/stocks/ASML)